Acquired thrombotic thrombocytopenic purpura · 3 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Methylprednisolone monotherapy Variant #02 | — | R 2 561 | 23d | — | — | — | — | — |
Vincristine monotherapy Variant #01 | — | R 358 | 14d | — | — | — | — | — |
Rituximab monotherapy N/A - secondary systemic drug | — | R 52 | 180d | ~20.3 mo | — | ~4 | ~R 208 PFS proxy · indirect | 20 |
3 of 3 regimens shown